- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02160457
Gait Analysis and Interdisciplinary Interventions for Children With Cerebral Palsy (CPinMotion)
Instrumented Gait Analysis and Individually Tailored Interdisciplinary Interventions for Children With Cerebral Palsy: A Randomized Controlled Trial
Study Overview
Detailed Description
Children with cerebral palsy (CP) who walk independently often have an altered gait pattern. Interdisciplinary interventions in terms of orthopaedic surgery, spasticity management, physical therapy and orthotics aim to improve the gait pattern. Standardised measurements are used in the Cerebral Palsy follow-Up Program to assess walking. However, these measurements do not describe features in the gait pattern reflecting underlying neuro-musculoskeletal impairments. This can be done with instrumented 3-dimensional gait analysis (IGA). It has never been investigated whether interdisciplinary interventions designed to address impairments identified by IGA result in improved gait pattern compared with 'care as usual' without IGA in children with CP. The aim of this study is to test the hypothesis, that improvements in gait pattern following individually tailored interventions guided by IGA are superior to those used in 'care as usual'.
A prospective, single blind, randomised, parallel group study will be conducted. Participants will be recruited from the Cerebral Palsy follow-Up Program. Children aged 5 to 9 years with spastic CP, classified at Gross Motor Function Classification System levels I or II will be included. The interventions under investigation are 1) Individually tailored interdisciplinary intervention addressing impairments identified by IGA and 2) 'care as usual' (interdisciplinary interventions without IGA). The primary outcome is gait pattern measured by the Gait Deviation Index. Secondary outcome measures are, walking performance and patient-reported outcomes of functional mobility, health-related quality of life and overall health, pain and participation. Explorative outcome measures include walking performance, gait pattern, behavior of health care providers and the applied interventions. The primary endpoint for assessing the outcome of the two interventions will be 52 weeks after start of intervention. A follow up will also be performed at 26 weeks after start of intervention; however, exclusively for the patient-reported outcomes.
To our knowledge, this is the first randomised controlled trial comparing the effects of an individually tailored interdisciplinary intervention designed to address impairments identified by IGA versus 'care as usual' in children with CP. Consequently, the study will provide novel evidence for the use of IGA in interdisciplinary interventions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Odense, Denmark
- University of Southern Denmark - Odense University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Spastic Cerebral palsy
- Gross Motor Function Classification System levels I or II.
Exclusion Criteria:
- Earlier interventions in the form of orthopaedic surgery within the past 52 weeks, injection with botulinum toxin type A in the 12 weeks prior to baseline assessments
- Relocation to another region during the trial.
- If the child not are able to demonstrate sufficient co-operation and cognitive understanding to participate in the IGA.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention with IGA
Individually tailored interdisciplinary intervention based on measures performed as part of the Cerebral Palsy follow-Up Program and other clinical examinations AND instrumented gait analysis (IGA)
|
Individually tailored interdisciplinary intervention based on measures performed as part of the Cerebral Palsy follow-Up Program and other clinical examinations AND instrumented gait analysis The instrumented gait analysis consists of four steps:
The two modalities differs in the use of IGA, but the study is not indented to document the effect of IGA alone, but to document the difference in the effects of the interdisciplinary interventions, when IGA is implemented to the experimental group.
Other Names:
|
No Intervention: Intervention without IGA
'Care as usual' - Individually tailored interdisciplinary interventions based on measures performed as part of the Cerebral Palsy follow-Up Program and other clinical examinations BUT NOT (IGA).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Gait Deviation Index
Time Frame: Baseline, 52 weeks
|
Gait Deviation Index (GDI) is based upon kinematic data from the Instrumented Gait Analysis, and is an quantitative index that summarises the overall gait pattern into a single score for each patient by comparison with non-pathological gait.
A GDI value of 100 represents the absence of gait pathology, and each 10-point decrement below 100 indicates one standard deviation from normal gait kinematics.
For the primary outcome measure, the median of five trials for each leg will be used to calculate the average of both legs to provide a single index for each child.
|
Baseline, 52 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in 1-minute walk test
Time Frame: Baseline, 52 weeks
|
Walking performance is assessed with the 1-minute walk test.
The test measure the distance in meters, when the child walks as fast as possible.
|
Baseline, 52 weeks
|
Change from baseline in Mobility Scale of the Pediatric Evaluation of Disability Inventory
Time Frame: Baseline, 52 weeks
|
The Mobility Scale of the Pediatric Evaluation of Disability Inventory evaluates the child's functional mobility in everyday activities with regard to functional skills and caregiver assistance.
The Paediatric Evaluation of Disability Inventory will be applied as a parental questionnaire, allowing comparison of the child's functional skills over time for each of the two dimensions.
|
Baseline, 52 weeks
|
Change from baseline in Pediatric Quality of Life Inventory Cerebral Palsy Module
Time Frame: Baseline, 52 weeks
|
The Pediatric Quality of Life Inventory Cerebral Palsy Module is a measure of health-related quality of life, specifically designed for children with CP.
The Pediatric Quality of Life Inventory Cerebral Palsy Module is based upon the parents' report and measures physical, emotional, social and school functioning.
|
Baseline, 52 weeks
|
Change from baseline in Pediatric Outcome Data Collection Instrument
Time Frame: Baseline, 52 weeks
|
The Pediatric Outcome Data Collection Instrument assesses overall health, pain and participation in normal daily activities.
|
Baseline, 52 weeks
|
Change from baseline in Mobility Scale of the Pediatric Evaluation of Disability Inventory
Time Frame: Baseline, 26 weeks
|
The Mobility Scale of the Pediatric Evaluation of Disability Inventory evaluates the child's functional mobility in everyday activities with regard to functional skills and caregiver assistance.
The Paediatric Evaluation of Disability Inventory will be applied as a parental questionnaire, allowing comparison of the child's functional skills over time for each of the two dimensions.
|
Baseline, 26 weeks
|
Change from baseline in Pediatric Quality of Life Inventory Cerebral Palsy Module
Time Frame: Baseline, 26 weeks
|
The Pediatric Quality of Life Inventory Cerebral Palsy Module is a measure of health-related quality of life, specifically designed for children with CP.
The Pediatric Quality of Life Inventory Cerebral Palsy Module is based upon the parents' report and measures physical, emotional, social and school functioning.
|
Baseline, 26 weeks
|
Change from baseline in Pediatric Outcome Data Collection Instrument
Time Frame: Baseline, 26 weeks
|
The Pediatric Outcome Data Collection Instrument assesses overall health, pain and participation in normal daily activities.
|
Baseline, 26 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Gait Variable Score
Time Frame: Baseline, 52 weeks
|
The Gait Variable Score is used to measure changes in gait pattern.
Gait Variable Score is an index for a single gait variable.
The Gait Variable Scores are determined for the following nine variables: Pelvic tilt, pelvic obliquity, pelvic rotation, hip flexion, hip adduction, hip rotation, knee flexion, dorsiflexion and foot progression
|
Baseline, 52 weeks
|
Change from baseline in Measure of Processes of Care
Time Frame: Baseline, 52 weeks
|
Measure of Processes of Care is a self-report measure of parents' perception of the extent to which the health services that their child receives are family-centred.
|
Baseline, 52 weeks
|
Applied interventions
Time Frame: 52 weeks
|
Records from the Cerebral Palsy Follow-Up Program of the applied interventions will be used to explore differences (used vs. not used) in the use of the following intervention categories in the two groups: Orthopaedic surgery, Spasticity management, Physical Therapy and Orthotics.
|
52 weeks
|
Difference in recommended and applied interventions
Time Frame: Baseline, 52 weeks
|
Records from the Cerebral Palsy Follow-Up Program of the recommended and actually applied interventions in the experimental group will be used to explore the differences (used vs. not used) in the recommended and actually applied interventions in regard to the following categories: Orthopaedic surgery, Spasticity management, Physical Therapy and Orthotics.
|
Baseline, 52 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Helle Rasmussen, Ph.d. stud., University of Southern Denmark and Odense University Hospital
- Study Chair: Anders Holsgaard-Larsen, Ph.d., University of Southern Denmark and Odense University Hospital
Publications and helpful links
General Publications
- Fonvig CE, Rasmussen HM, Overgaard S, Holsgaard-Larsen A. Effectiveness of instrumented gait analysis in interdisciplinary interventions on parents' perception of family-centered service and on gross motor function in children with cerebral palsy: a randomized controlled trial. BMC Pediatr. 2020 Sep 1;20(1):411. doi: 10.1186/s12887-020-02315-2.
- Rasmussen HM, Pedersen NW, Overgaard S, Hansen LK, Dunkhase-Heinl U, Petkov Y, Engell V, Baker R, Holsgaard-Larsen A. The use of instrumented gait analysis for individually tailored interdisciplinary interventions in children with cerebral palsy: a randomised controlled trial protocol. BMC Pediatr. 2015 Dec 7;15:202. doi: 10.1186/s12887-015-0520-7.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-20120162
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
-
Northwestern UniversityActive, not recruitingCerebral Palsy | Diplegic Cerebral Palsy | Bilateral Cerebral PalsyUnited States
-
Centre Médico-Chirurgical de Réadaptation des Massues...RecruitingCerebral Palsy, Dyskinetic | Cerebral Palsy, Spastic | Infantile Hemiplegic Cerebral PalsyFrance
-
St Mary's University CollegeUniversity of GloucestershireUnknownCerebral Palsy | Cerebral Palsy Ataxic | Cerebral Palsy, MixedUnited Kingdom
-
Hilde FeysHasselt University; ETH Zurich; Curtin UniversityRecruitingHemiplegic Cerebral Palsy | Cerebral Palsy, SpasticBelgium
-
University of California, San FranciscoNational Institutes of Health (NIH)RecruitingDystonic Cerebral Palsy | Dyskinetic Cerebral PalsyUnited States
-
MTI UniversityEnrolling by invitationSpastic Diplegic Cerebral PalsyEgypt
-
East Carolina UniversityRecruitingHemiplegic Cerebral Palsy | Unilateral Cerebral Palsy | Remote Ischemic ConditioningUnited States
-
October 6 UniversityCompletedSpastic Cerebral Palsy | Spastic Hemiplegic Cerebral PalsyEgypt
-
Marmara UniversityUnknownCerebral Palsy, Spastic | Cerebral Palsy, Spastic, DiplegicTurkey
Clinical Trials on Intervention with IGA
-
Zhongshan People's Hospital, Guangdong, ChinaWuzhou Red Cross Hospital; Xiamen UniversityRecruitingNasopharyngeal CarcinomaChina
-
London School of Hygiene and Tropical MedicineUniversity College London Hospitals; World Health Organization; RTI International and other collaboratorsTerminated
-
Sun Yat-sen UniversityCancer Research Institute of Zhongshan City; Sihui Cancer InstituteActive, not recruitingNasopharyngeal Cancer | Morality | ScreeningChina
-
University Hospital, RouenNot yet recruiting
-
Arog Pharmaceuticals, Inc.CompletedRecurrent/Refractory GlioblastomaUnited States
-
Germanna de Medeiros BarbosaCompletedNeuromuscular Manifestations
-
University of Texas at AustinNational Cattlemen's Beef AssociationRecruitingEating Behavior | Breast Feeding, Exclusive | Glycemic ResponseUnited States
-
University of Sao PauloFederal University of São PauloRecruitingRenal Insufficiency, ChronicBrazil
-
Institute of Psychiatry and Neurology, WarsawUnknown
-
Nutrition Institute, SloveniaMEDEDUS, Ljubljana, Slovenia; Vizera d.o.o.; Valens Int. d.o.o., SlovenijaCompletedBioavailability of Coenzyme Q10Slovenia